Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasms
Interventions: DRUG: Bevacizumab|DRUG: Anastrozole|DRUG: Fulvestrant
Sponsor: SCRI Development Innovations, LLC
Collaborators: Genentech, Inc.|AstraZeneca